X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4) 4
index medicus (4) 4
aged (3) 3
clinical trials (3) 3
disease-free survival (3) 3
female (3) 3
lung cancer (3) 3
lung cancer, non-small cell (3) 3
male (3) 3
middle aged (3) 3
nsclc (3) 3
oncology (3) 3
treatment outcome (3) 3
abridged index medicus (2) 2
adult (2) 2
aged, 80 and over (2) 2
analysis (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
care and treatment (2) 2
chemotherapy (2) 2
kaplan-meier estimate (2) 2
medical colleges (2) 2
mutation (2) 2
patients (2) 2
tumors (2) 2
adenocarcinoma (1) 1
algorithms (1) 1
anca-associated vasculitis (1) 1
anti-pd-l1 antibody (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antibody-associated vasculitis (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
automobile industry (1) 1
azathioprine - administration & dosage (1) 1
azathioprine - adverse effects (1) 1
azathioprine - therapeutic use (1) 1
b7-h1 antigen - analysis (1) 1
bildgeführtes verfahren (1) 1
biological transport (1) 1
biomarkers (1) 1
biopsy (1) 1
blockade (1) 1
cancer therapies (1) 1
carcinoma, non-small-cell lung - chemistry (1) 1
carcinoma, non-small-cell lung - diagnostic imaging (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - metabolism (1) 1
carcinoma, non-small-cell lung - therapy (1) 1
cardiology (1) 1
cell survival (1) 1
churg-strauss-syndrome (1) 1
confidence intervals (1) 1
criteria (1) 1
cyclin-dependent kinases (1) 1
docetaxel (1) 1
drug administration schedule (1) 1
drug-related side effects and adverse reactions - classification (1) 1
drug-related side effects and adverse reactions - genetics (1) 1
drug-related side effects and adverse reactions - physiopathology (1) 1
erlotinib (1) 1
f-18-fdg pet (1) 1
fda approval (1) 1
follow-up (1) 1
follow-up studies (1) 1
forschungsorganisation (1) 1
gefitinib (1) 1
gene expression regulation, neoplastic (1) 1
genes (1) 1
granulomatosis with polyangiitis - drug therapy (1) 1
granulomatosis with polyangiitis - mortality (1) 1
harmonic analysis (1) 1
harmonisierung (1) 1
hematology, oncology and palliative medicine (1) 1
image processing, computer-assisted (1) 1
image-reconstruction (1) 1
imaging / radiology (1) 1
immunotherapy (1) 1
impact (1) 1
interactive systems (1) 1
internal medicine (1) 1
kidney - drug effects (1) 1
lung cancer, small cell (1) 1
lung neoplasms - chemistry (1) 1
lung neoplasms - diagnostic imaging (1) 1
lung neoplasms - drug therapy (1) 1
lung neoplasms - metabolism (1) 1
lung neoplasms - pathology (1) 1
lung neoplasms - therapy (1) 1
lungenkrebs (1) 1
medical centres (1) 1
medical prognosis (1) 1
medical services (1) 1
medical treatment (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1540 - 1550
Summary Background Despite recent advances in the treatment of advanced non-small-cell lung cancer, there remains a need for effective treatments for... 
Internal Medicine | CRITERIA | MEDICINE, GENERAL & INTERNAL | ANTI-PD-L1 ANTIBODY | THERAPY | NSCLC | IMMUNOTHERAPY | PD-L1 | BLOCKADE | NIVOLUMAB | CHEMOTHERAPY | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Patient Selection | Taxoids - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Adult | Female | Taxoids - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Lung Neoplasms - chemistry | Docetaxel | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Taxoids - administration & dosage | Aged | B7-H1 Antigen - analysis | Carcinoma, Non-Small-Cell Lung - drug therapy | Antimitotic agents | Medical colleges | Lung cancer, Non-small cell | Antineoplastic agents | Analysis | Chemotherapy | Biopsy | Genes | Lung cancer | Clinical trials | Oncology | Mutation | Tumors | Slopes | Cell survival | Medical treatment | Medical services | FDA approval | Survival | Patients | Medical centres | Pembrolizumab | Randomization | Interactive systems | Immunotherapy | Risk assessment | PD-L1 protein | Biomarkers
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 5, pp. 577 - 589
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2013, Volume 40, Issue 7, pp. 985 - 996
Journal Article
by Puéchal, Xavier and Pagnoux, Christian and Perrodeau, Élodie and Hamidou, Mohamed and Boffa, Jean‐Jacques and Kyndt, Xavier and Lifermann, François and Papo, Thomas and Merrien, Dominique and Smail, Amar and Delaval, Philippe and Hanrotel‐Saliou, Catherine and Imbert, Bernard and Khouatra, Chahéra and Lambert, Marc and Leské, Charles and Ly, Kim H and Pertuiset, Edouard and Roblot, Pascal and Ruivard, Marc and Subra, Jean‐François and Viallard, Jean‐François and Terrier, Benjamin and Cohen, Pascal and Mouthon, Luc and Le Jeunne, Claire and Ravaud, Philippe and Guillevin, Loïc and Rispal, P and Baidi, N and Chrétien, O and Cevallos, R and Ducroix, J.‐P and Darmaillacq, J.‐G and Dubas†, F and Maghakian, M.‐N and Moreau, C and Dubos‐Arvis, C and Frognier, R and Gobert, P and Pollini, J and Pingat, D and Janin‐Manificat, L and Lafon, B and Kettaneh, A and Moiton, M and Ragnaud, J. M and Boudray, C and Raphanel, B and Renand, J.‐P and Roux, M and Bonnaire, G and Guiso, A and André, J. M and Perrichot, R and Louvet, J and Artigues, N and Bienvenu, B and Hurault de Ligny, B and Le Hello, C and Letellier, P and Lobbedez, T and Ollivier, Y and Pujo, M and Ryckelynck, J.‐P and Montseny, J.‐J and Collet, P and Ayach, B and Dion, J.‐J and Mouawad, H and Damade, R and Dupouët, L and Asgaraly, K and Depernet, B and Colin, T and Ioos, V and Rieu, V and Belmatoug, N and Foulon, L and Jebrak, G and du Coedic, L and Bachmeyer, C and Dumoulin, A and Godeau, B and Khellaf, M and Michel, M and Pastural, M and Schaeffer, A and Geffroy, M and Bielefeld, P and Fichet, D and Saraux, J.‐L and Vinzio, S and Ehrlacher, P and Azria, A and Mariette, X and Tiab, M and Delansorne, D and Boullanger, N and Closs‐Prophette, F and ... and French Vasculitis Study Grp and French Vasculitis Study Group
Arthritis & Rheumatology, ISSN 2326-5191, 03/2016, Volume 68, Issue 3, pp. 690 - 701
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.